Share Twitter LinkedIn Facebook Email Yogenthiran Saunthararajah, MD of Cleveland Clinic, discusses the current updates and trends surrounding treatment in Sickle Cell Disease at the 58th ASH Annual Meeting in San Diego, CA.
Sherif Badawy, MD @LurieChildrens #SickleCellAnemia #Cancer #Research A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy Sickle Cell 2 Mins Read
Andrés Cervantes, MD @AndresC27622123 @Pivotal #gastrointestialcancer #cancer #research Phase IIa trial to examine Gastro-Intestinal cancer therapy Sickle Cell 2 Mins Read
Francesca Vinchi, Ph.D. @IronResearchLab @NYBloodCenter #sicklecellanemia “Breaking up†in Sickle Cell Anemia Sickle Cell 2 Mins Read
